↑Wan i inni, (S)-Oxiracetam is the Active Ingredient in Oxiracetam that Alleviates the Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats, „Scientific Reports”, 7 (1), 2017, DOI: 10.1038/s41598-017-10283-4, PMID: 28855592, PMCID: PMC5577264(ang.).
↑Andrei G.A.G.MalykhAndrei G.A.G., M. RezaM.R.SadaieM. RezaM.R., Piracetam and Piracetam-Like Drugs: From Basic Science to Novel Clinical Applications to CNS Disorders, „Drugs”, 70 (3), 2010, s. 287–312, DOI: 10.2165/11319230-000000000-00000(ang.).
↑L.L.ParnettiL.L. i inni, Neuropsychological Results of Long-Term Therapy with Oxiracetam in Patients with Dementia of Alzheimer Type and Multi-Infarct Dementia in Comparison with a Control Group, „Neuropsychobiology”, 22 (2), 1989, s. 97–100, DOI: 10.1159/000118599(ang.).
↑Anna MariaA.M.PuglieseAnna MariaA.M. i inni, Effect of the nootropic drug oxiracetam on field potentials of rat hippocampal slices, „British Journal of Pharmacology”, 99 (1), 1990, s. 189–193, DOI: 10.1111/j.1476-5381.1990.tb14676.x, PMID: 1970492, PMCID: PMC1917508(ang.).